GlassScriptPhysician profile
Sandea Greene-Harris
NPI 1295784429
$77,298.90
in general payments reported to CMS, 2019-2025
19 companies · $16K in 2025
The $16K reported for 2025 was more than what 88% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,177 · 2020: $27K · 2021: $6,654 · 2022: $15K · 2023: $644 · 2024: $9,015 · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $20K · Food and Beverage: $2,884 · Travel and Lodging: $2,510.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,230.00 |
| Food and Beverage | $2,884.14 |
| Travel and Lodging | $2,509.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $44,008.11 | 2021-2025 | Stealthstation S8 Platform, O-Arm, Mazor X System |
| Stryker Corporation | $30,050.78 | 2019-2024 | Core, N/A |
| Si-Bone, INC. | $1,031.81 | 2019-2025 | |
| Depuy Synthes Sales INC. | $696.38 | 2022-2025 | Matrixneuro, Trumatch, Synthecel |
| Boston Scientific Corporation | $491.20 | 2022-2025 | Wavewriter Alpha Prime 16, General - Therapies, Axonics |
| Globus Medical, INC. | $453.65 | 2025 | Excelsius Gps, Coalition Agx, Acp |
| Nevro Corp. | $120.89 | 2023 | Senza |
| Smith+Nephew, INC. | $74.42 | 2025 | Stravix, Grafix |
| Inspire Medical Systems, INC. | $63.87 | 2024 | Inspire |
| Bioventus LLC | $53.11 | 2025 | Bonescalpel & Sonicone (O.R.) |
| Astrazeneca Pharmaceuticals LP | $47.89 | 2023 | Andexxa |
| Ethicon US, LLC | $46.47 | 2025 | Dermabond Prineo, Surgiflo Hemostatic Matrix, Vistaseal |
| Kyocera Medical Technologies, INC. | $40.80 | 2024-2025 | |
| Aesculap, INC. | $30.15 | 2025 | No Applicable Marketed Product Name |
| Biotronik Nro, INC. | $21.67 | 2024 | Prospera |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $20.31 | 2023 | Floseal |
| Integra Lifesciences Corporation | $19.47 | 2024 | Codman Hakim, Cusa Clarity, Codman Certas |
| Spine Wave, INC. | $15.58 | 2024 | Annex Adjacent Level System |
| Lemaitre Vascular, INC. | $12.34 | 2023 | Anastoclip Gc 8cm (Medium) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandea Greene-Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.